F18.159

Clinical Causes: Prolonged or repeated inhalation of volatile substances such as glue, paint fumes, aerosol sprays, or gasoline. Experimentation driven by curiosity, peer pressure, or a desire for euphoria. Underlying mental health conditions that increase vulnerability to substance misuse. Environmental factors, including easy access to inhalants and social acceptance among peers. Lack of awareness about the harmful effects of inhalant use.

Key Symptoms: Euphoric or intoxicated feeling after inhalation. Confusion, disorientation, or difficulty concentrating. Auditory or visual hallucinations. Paranoia, suspiciousness, or delusional thinking. Agitation, irritability, or aggressive behavior. Physical symptoms such as dizziness, nausea, headaches, or muscle weakness. Poor coordination and motor control issues. Changes in sleep patterns or appetite. Possible loss of consciousness in severe cases.

Diagnosis Path: Diagnosis typically involves a comprehensive assessment by a mental health or medical professional, including a detailed history of substance use, mental health evaluation, and physical examination. Healthcare providers may utilize screening tools and laboratory tests to detect inhalant exposure. The physician will aim to rule out other causes of psychosis and confirm the link between inhalant use and the psychotic symptoms.

Treatment Protocols: Detoxification and cessation of inhalant use with medical supervision. Psychotherapy approaches such as cognitive-behavioral therapy (CBT) to address underlying issues and modify harmful behaviors. Medication management may be considered to alleviate psychotic symptoms, such as antipsychotic drugs, under medical supervision. Support groups and counseling to promote recovery and prevent relapse. Educational programs to increase awareness about the dangers of inhalant abuse.